Integrative Analysis Reveals a Molecular Stratification of Systemic Autoimmune Diseases

Guillermo Barturen(Universidad de Granada), Alfonso Corrales Martínez(Marqués de Valdecilla University Hospital), Ralf Lesche(Howard Hughes Medical Institute), Nancy Azevedo(Centro Hospitalar do Porto), Zuzanna Makowska(University Hospital of Basel), Elena Trombetta(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Elena Carnero‐Montoro(Universitat Pompeu Fabra), Jordi Martorell‐Marugán(Pfizer-University of Granada-Junta de Andalucía Centre for Genomics and Oncological Research), Carlos Vasconcelos(Hospital de Santo António), Sepideh Babaei(Bayer (Germany)), Ana Campar(Centro Hospitalar do Porto), Concepción Marañón(Karolinska University Hospital), Marialbert Acosta‐Herrera(Instituto de Investigación Biosanitaria de Granada), Francesc Català‐Moll(IrsiCaixa), Esmeralda Neves(Universidade do Porto), Javier Rodríguez‐Ubreva(Josep Carreras Leukaemia Research Institute), Anne Buttgereit(Bayer (Germany)), Mariana Brandão(Centro Hospitalar do Porto), Tânia Gomes Anjos(Universidad de Granada), Sikander Hayat(Universitätsklinikum Aachen), Gaia Montanelli(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Rocío Aguilar‐Quesada(Instituto de Investigación Biosanitaria de Granada), Francisco Javier Garrancho(Andalusian School of Public Health), María P. Hernández-Fuentes(King's College London), António Marinho(Centro Hospitalar do Porto), Barbara Vigone(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Héctor Navarro‐Linares(Andalusian School of Public Health), Tania F. Rowley(UCB Pharma (United Kingdom)), Jorge Kageyama(Max Planck Institute for Developmental Biology), Fátima Farinha(Centro Hospitalar do Porto), Christophe Jamin(Inserm), Antonio García-Gómez(Institut d'Investigació Biomédica de Bellvitge), Raquel Faria(CUF Porto Hospital), Isabel Almeida(Centro Hospitalar do Porto), Pedro Carmona‐Sáez(Pfizer-University of Granada-Junta de Andalucía Centre for Genomics and Oncological Research), Manuel Martínez‐Bueno(Pfizer-University of Granada-Junta de Andalucía Centre for Genomics and Oncological Research), Tianlu Li(Institut d'Investigació Biomédica de Bellvitge), Daniel Toro‐Domínguez(Pfizer-University of Granada-Junta de Andalucía Centre for Genomics and Oncological Research), Manuel Rodríguez Maresca(Andalusian School of Public Health), Martin Kerick(Instituto de Parasitología y Biomedicina "López - Neyra"), Maria Juárez(UCB Pharma (United Kingdom)), Joerg Mueller(Bayer (Germany)), Nieves Varela(Pfizer-University of Granada-Junta de Andalucía Centre for Genomics and Oncological Research), Ana Tavares(Centro Hospitalar do Porto), Ian N.H. White(UCB Pharma (United Kingdom)), María Teruel(Consejo Superior de Investigaciones Científicas), Lucas Le Lann(Inserm), Damiana Álvarez‐Errico(Institut Municipal d'Assistència Sanitària), Antonio López‐Berrio(Andalusian School of Public Health)
medRxiv
February 23, 2020
Cited by 22


Related Papers